Egetis Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BST:P0F Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
08 Nov 24	Buy€2,154	Christian Sonesson	Individual	6,000	€0.36
08 Nov 24	Buy€24,115	Henrik Krook	Individual	65,000	€0.37
07 Oct 24	Buy€3,716	Yilmaz Mahshid	Individual	10,000	€0.37
07 Oct 24	Buy€3,791	Nicklas Westerholm	Individual	10,142	€0.37

Insider Trading Volume

Insider Buying: P0F insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of P0F?
Owner Type	Number of Shares	Ownership Percentage
VC/PE Firms	38,675,501	10.8%
Individual Insiders	48,059,328	13.4%
Private Companies	61,976,211	17.3%
Institutions	65,711,675	18.3%
General Public	144,815,411	40.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 22.8%.

Top Shareholders

Top 25 shareholders own 59.65% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.8%	Frazier Life Sciences Management, LP	38,675,501	€21.2m	0%	0.89%
9.4%	Cetoros AB	33,776,221	€18.5m	0%	no data
8.35%	Peter Lindell	30,007,682	€16.5m	0%	no data
5.96%	Fourth Swedish National Pension Fund (AP4)	21,404,690	€11.7m	0%	0.05%
4.92%	Avla Holding AB	17,668,330	€9.7m	0%	no data
3.85%	Flerie AB (publ)	13,844,458	€7.6m	0%	13.56%
3.76%	Thomas Eldered	13,499,458	€7.4m	0%	no data
3.29%	Handelsbanken Asset Management	11,831,897	€6.5m	0%	0.01%
2.93%	Recipharm AB (publ)	10,531,660	€5.8m	0%	no data
2.1%	Linc AB	7,532,021	€4.1m	0%	1.99%
1.93%	Unionen, Endowment Arm	6,946,793	€3.8m	0%	1.25%
0.87%	Mats Blom	3,134,762	€1.7m	0%	no data
0.43%	SEB Investment Management AB	1,538,387	€843.7k	1.21%	no data
0.28%	Swedbank Robur Fonder AB	1,000,000	€548.4k	0%	no data
0.21%	FCG Fonder AB	772,249	€423.5k	0%	0.05%
0.11%	Henrik Krook	404,593	€221.9k	19.1%	no data
0.087%	Yilmaz Mahshid	313,089	€171.7k	3.3%	no data
0.086%	Financiere Arbevel	310,000	€170.0k	0%	0.04%
0.079%	Thomas Lonngren	283,158	€155.3k	0%	no data
0.07%	Avanza Fonder AB	250,662	€137.5k	0%	no data
0.068%	Nicklas Westerholm	242,718	€133.1k	4.36%	no data
0.049%	Skandia Fonder AB	176,659	€96.9k	0%	no data
0.021%	Storebrand Fonder AB,	73,895	€40.5k	0%	no data
0.012%	Christian Sonesson	42,298	€23.2k	16.5%	no data
0.011%	Gunilla Osswald	40,000	€21.9k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/11 09:40
End of Day Share Price	2025/01/06 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Egetis Therapeutics AB (publ) is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
null null	ABG Sundal Collier
Patrick Langstrom	ABG Sundal Collier Sponsored
Oscar Haffen Lamm	Bryan Garnier & Co